Comparison between the Role of Platelet rich Fibrin and Advanced Platelet rich Fibrin in the Management of cysts after enucleation â??

A Comparative Study to Evaluate the Role of Platelet rich Fibrin(PRF) and Advanced Platelet rich Fibrin (APRF) in the Management of cyst after enucleation â?? - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070252

Enrollment

Registered

2024-07-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K099- Cyst of oral region, unspecified Health Condition 2: Z40-Z53- Encounters for other specific health care

Interventions

Intervention1: Advanced Platelet rich Fibrin: PRF type ,made from patients own blood and placed in cavity after enucleation of cyst, duration of evaluation 6 months Control Intervention1: Platelet ric

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are willing to participate. Patients of any age group and gender with ASA1. Patients having cysts of size - small to medium ( less than 5 cm ). Cyst of a benign nature.

Exclusion criteria

Exclusion criteria: Patients having large cysts ( more than 5 cm ). Suspicious cyst that may need further excision and malignant cystic lesion. Cases indicated for segmental mandibulectomy. Medically compromised patients and patients on blood thinners and thrombocytopenia.

Design outcomes

Primary

Measure	Time frame
soft tissue healing and bone formationTimepoint: 1 week and 2nd & 6th month respectively.	—

Secondary

Measure	Time frame
any other relevant finding during hard and soft tissue healingTimepoint: with in 6 months	—

Countries

India

Contacts

Public ContactDr Richa Yadav

Panjab University

hemant_batra69@yahoo.com9814555550

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026